PainChek Limited (ASX:PCK)
Australia · Delayed Price · Currency is AUD 0.1250
+0.0100 (8.70%)
Sep 9, 2026, 3:43 PM AEST
PainChek Revenue
In the fiscal year ending June 30, 2026, PainChek had annual revenue of 3.74M AUD with 11.29% growth. PainChek had revenue of 2.01M in the half year ending June 30, 2026, with 46.81% growth.
Revenue
3.74M
Revenue Growth
+11.29%
P/S Ratio
6.42
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 3.74M | 379.64K | 11.29% |
| Jun 30, 2025 | 3.36M | 690.49K | 25.84% |
| Jun 30, 2024 | 2.67M | 716.07K | 36.61% |
| Jun 30, 2023 | 1.96M | 961.72K | 96.74% |
| Jun 30, 2022 | 994.15K | 760.26K | 325.05% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Doctor Care Anywhere Group | 75.18M |
| Beamtree Holdings | 29.19M |
| Resonance Health | 15.75M |
| Pharmx Technologies | 7.62M |
| Careteq | 6.08M |
| Vitasora Health | 4.84M |
| Emyria | 4.05M |
| Intelicare Holdings | 2.04M |